Cancer Care Ontario | Cancer Care Ontario

You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.

Skip to main content Skip to search

56 Results

Guidelines and Advice

Molecular Analyses in the Diagnosis, Prognosis, and Selection of Therapy in non-GIST Soft Tissue Sarcomas

Status: Archived
ID: GL 11-12

Apr 2018

Guidelines and Advice

Guidance for Kyphoplasty and Vertebroplasty for Cancer Patients in Ontario: Recommendations Report 2017

Status: Current
Version: 2

Oct 2018

Guidelines and Advice

Immune Checkpoint Inhibitor Toxicity Management Clinical Practice Guideline

Status: Current
Version: 1

Mar 2018

Guidelines and Advice

Patient Indications for Mohs Micrographic Surgery

Status: Current
ID: GL 8-11

Jan 2018

Guidelines and Advice

Three-Dimensional MR-Guided Intracavitary and Interstitial Brachytherapy for Cervical Cancer

Status: Current
ID: GL 21-2v2
Version: 2

Nov 2018

Guidelines and Advice

Surgical Management of Patients with Lymph Node Metastases from Cutaneous Melanoma of the Trunk or Extremities

Status: Current
ID: 8-6
Version: 2

Aug 2018

Guidelines and Advice

Cancer Care Ontario Beyond-Use Date Recommendations Report

Status: Current
ID: N/A
Version: 1

Mar 2018

Cancer facts

Liver cancer incidence rates have increased in Ontario

Dec 2018

Cancer facts

Over 1,300 annual cancer cases caused by HPV could be prevented in Ontario

Oct 2018

Cancer facts

Female thyroid cancer incidence varies across geographic regions in Ontario

Jul 2018

Guidelines and Advice

Guidelines on Management of Nausea and Vomiting and on Loss of Appetite, Anorexia, and Cachexia in Cancer

Status: Current
ID: ES SMG-2

Jun 2018

Guidelines and Advice

PET Evidence from Primary Studies and Systematic Reviews and Recommendations from Clinical Practice Guidelines July to December 2017

Status: Current
ID: PET 2017-2
Version: n/a

May 2018

Pages